Bacterial Infections  >>  RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
NCT01926015 / 2017-000277-37: Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)

Completed
4
192
NA
RotaTeq™ (V260), RotaTeq™, DTP-IPV, Tetrabik™, BIKEN
Merck Sharp & Dohme LLC
Rotavirus Disease
06/14
06/14

Download Options